Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental sulphamethoxazole poisoning |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional sulphamethoxazole poisoning |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le sulfaméthoxazole d'intention indéterminée |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by sulfamethoxazole |
Causative agent (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulphamethoxazole + trimethoprim 200mg/40mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole + trimethoprim 400mg/80mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole + trimethoprim 800mg/160mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 400mg/trimethoprim 80mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 80mg/trimethoprim 16mg infusion solution ampoule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole measurement |
Component |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 100 milligram and trimethoprim 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine- and sulfamethoxazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Azo-Sulfamethoxazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental sulphamethoxazole poisoning |
Causative agent (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional sulphamethoxazole poisoning |
Causative agent (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
intoxication par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
intoxication accidentelle par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
intoxication intentionnelle par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
intoxication par le sulfaméthoxazole et triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole + trimethoprim adverse reaction |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose accidentelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose intentionnelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de sulfaméthoxazole et triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 80mg/400mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 160mg/800mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 120mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 240mg/5mL pediatric suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 480mg/5mL intravenous infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 40mg/200mg/5mL pediatric s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 960mg/10mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral sulfamethoxazole+trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing sulfamethoxazole and trimethoprim in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by sulfamethoxazole (disorder) |
Causative agent (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 96mg/mL infusion solution 20mL ampule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
sulfaméthoxazole et triméthoprime |
Is a |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 100 milligram and trimethoprim 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 100 milligram and trimethoprim 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sulfamethoxazole 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 100 milligram and trimethoprim 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has precise active ingredient |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
Has basis of strength substance (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
Has precise active ingredient |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
sulfaméthoxazole et triméthoprime |
Is modification of (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
Has basis of strength substance (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
Has precise active ingredient |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing sulfamethoxazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing phenazopyridine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Phenazopyridine and sulfamethoxazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only phenazopyridine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sulfamethoxazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole and trimethoprim only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sulfamethoxazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulphamethoxazole - chemical |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |